Safe Medical inaugurates its Integrated Innovation and Production Centre (CIPI) on the Fleurieux-sur-l'Arbresle (69) industrial site
13 Oktober 2021 - 05:45PM
Safe Medical inaugurates its Integrated Innovation and Production
Centre (CIPI) on the Fleurieux-sur-l'Arbresle (69) industrial site
Safe Medical inaugurates its Integrated
Innovation and Production Centre (CIPI) on the
Fleurieux-sur-l'Arbresle (69) industrial site
- A titanium 3D printing module and a clean room
dedicated to packaging complete the existing
facilities
- 2.5M€ have been invested in the Safe Medical site since
its acquisition by Safe Orthopaedics in 2020
- A leading industrial complex in Europe for the
innovation and production of orthopedic surgery medical
devices
|
|
|
|
Éragny-sur-Oise,
Fleurieux-sur-l'Arbresle, October 13, 2021 at 5:45 pm CET
- Safe Orthopaedics (FR0013467123 - ALSAF), a company specializing
in the design, manufacture and marketing of ready-to-use
technologies for back surgery, particularly safe for
emergency-treated vertebral fractures, has announced the
inauguration of its Center for Innovation and Integrated Production
(CIPI), on the Fleurieux-sur-l'Arbresle (69) industrial site.
Operational since September, the CIPI includes two clean rooms
dedicated to the packaging of medical devices and a titanium 3D
printing module for the design of implants and surgical tools. It
complements the production lines and the R&D unit set up in
2020 and entirely dedicated to orthopedic surgery.
Safe Orthopaedics acquired Safe Medical (Ex-LCI
Medical) in 2020. Since then, the company has invested €2.5 million
in the Fleurieux-sur-l'Arbresle site, making it a leading
industrial complex in Europe for the innovation and production of
medical devices for orthopedic surgery. One million euros were
devoted to the renovation and extension of the buildings, and
nearly 1.5 million to the technological re-equipment of the site
(1.5 million euros). The Safe Group received support from Bpifrance
for this project, via a €0.8 million innovation loan.
The activity of the Safe Medical site is driven
by the recovery of the subcontracting activity, with volumes now
higher than their pre-crisis level, and by the internationalisation
of the production of Safe Orthopaedics' proprietary
innovations.
Pierre Dumouchel, Chairman and CEO of
Safe Orthopaedics, said: “We are delighted that our
Integrated Innovation and Production Centre (CIPI) is now up and
running, in line with the timetable we set ourselves a year ago
when we launched the work. The integration of the entire value
chain, from R&D to manufacturing, on the same site allows us to
streamline our processes, with an economic and environmental
impact, while also giving us the means to radically accelerate the
innovation cycle. We will continue to invest in the
Fleurieux-sur-l'Arbresle site to maintain the excellence of this
industrial site and ensure our leadership in spine surgery.”
About Safe GroupSafe Group is a
French medical technology group that brings together Safe
Orthopaedics, a pioneer in ready-to-use technologies for spine
pathologies, and Safe Medical (formerly LCI Medical), a
subcontractor of medical devices for orthopedic surgery. The group
employs approximately 150 people.
Safe Orthopaedics develops and manufactures kits
combining sterile implants and single-use instruments, available at
any time to the surgeon. These technologies are part of a minimally
invasive approach aimed at reducing the risk of contamination and
infection, for the benefit of the patient and with a positive
impact on hospitalization times and costs. Protected by 18
patent families, SteriSpineTM kits are CE marked and FDA approved.
Safe Orthopaedics is headquartered in the Paris region
(Eragny-sur-Oise (95610)) and has subsidiaries in the United
Kingdom, Germany, the United States and the Lyon region
(Fleurieux-sur-l'Arbresle).
For more information:
www.safeorthopaedics.com
Safe Medical produces implantable medical
devices and ready-to-use instruments. It has an innovation centre
and two production sites in France (Fleurieux-sur-l'Arbresle,
69210) and Tunisia, offering a wide range of industrial services:
design, industrialisation, machining, finishing and sterile
packaging. Supported by the French recovery plan in 2020, the
company invests in additive printing and will be operational in
2022 on this new technology.
For more information: www.safemedical.fr
Contacts
Safe
Orthopaedics
François-Henri Reynaud
Chief Financial and Administrative Officer
Tél. : +33 (0)1 34 21 50
00
investors@safeorthopaedics.com
Press RelationsUlysse
CommunicationPierre-Louis Germain / +33 (0)6 64 79
97 51 / plgermain@ulysse-communication.comBruno
Arabian / +33 (0)6 87 88 47 26 /
barabian@ulysse-communication.com
- PR CIPI inauguration vdef
SAFE (EU:ALSAF)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
SAFE (EU:ALSAF)
Historical Stock Chart
Von Mär 2023 bis Mär 2024